title: LiF TLD-100 as a dosimeter in high energy proton beam therapy--can it yield accurate results?
abstract: In the region of high-dose gradients at the end of the proton range, the stopping power ratio of the protons undergoes significant changes, allowing for a broad spectrum of proton energies to be deposited within a relatively small volume. Because of the potential linear energy transfer dependence of LiF TLD-100 (thermolumescent dosimeter), dose measurements made in the distal fall-off region of a proton beam may be less accurate than those made in regions of low-dose gradients. The purpose of this study is to determine the accuracy and precision of dose measured using TLD-100 for a pristine Bragg peak, particularly in the distal fall-off region. All measurements were made along the central axis of an unmodulated 200-MeV proton beam from a Probeat passive beam-scattering proton accelerator (Hitachi, Ltd., Tokyo, Japan) at varying depths along the Bragg peak. Measurements were made using TLD-100 powder flat packs, placed in a virtual water slab phantom. The measurements were repeated using a parallel plate ionization chamber. The dose measurements using TLD-100 in a proton beam were accurate to within +/-5.0% of the expected dose, previously seen in our past photon and electron measurements. The ionization chamber and the TLD relative dose measurements agreed well with each other. Absolute dose measurements using TLD agreed with ionization chamber measurements to within +/- 3.0 cGy, for an exposure of 100 cGy. In our study, the differences in the dose measured by the ionization chamber and those measured by TLD-100 were minimal, indicating that the accuracy and precision of measurements made in the distal fall-off region of a pristine Bragg peak is within the expected range. Thus, the rapid change in stopping power ratios at the end of the range should not affect such measurements, and TLD-100 may be used with confidence as an in vivo dosimeter for proton beam therapy.
authors.affiliation: The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. zulloj@yahoo.com
authors.forename: John R
authors.initials: JR
authors.lastname: Zullo
authors.forename: Rajat J
authors.initials: RJ
authors.lastname: Kudchadker
authors.forename: X Ronald
authors.initials: XR
authors.lastname: Zhu
authors.forename: Narayan
authors.initials: N
authors.lastname: Sahoo
authors.forename: Michael T
authors.initials: MT
authors.lastname: Gillin
mesh_terms: D004867:Equipment Design; D019544:Equipment Failure Analysis; D011522:Protons; D011879:Radiotherapy Dosage; D020266:Radiotherapy, Conformal / Q000295:instrumentation*; D011882:Radiotherapy, High-Energy / Q000295:instrumentation*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013819:Thermoluminescent Dosimetry / Q000295:instrumentation*
chemical_list: D011522:Protons